Ascendis Pharma A (ASND) EBIT Margin Growth (1y) (2015 - 2026)
Ascendis Pharma A (ASND) EBIT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | 11,329.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,329.00 |
| Dec 31, 2025 | -12.36 Mn |
| Sep 30, 2025 | 17,243.00 |
| Jun 30, 2025 | 33,668.00 |
| Mar 31, 2025 | -5,198.00 |
| Dec 31, 2024 | 12.36 Mn |
| Sep 30, 2024 | 11,254.00 |
| Jun 30, 2024 | -7,301.00 |
| Mar 31, 2024 | 37,652.00 |
| Dec 31, 2023 | 63,166.00 |
| Sep 30, 2023 | 66,528.00 |
| Jun 30, 2023 | 200,629.00 |
| Mar 31, 2023 | 144,728.00 |
| Dec 31, 2022 | -51,304.00 |
| Sep 30, 2022 | 776,398.00 |
| Jun 30, 2022 | 920,623.00 |
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 768.00 |
| Sep 30, 2021 | -584,999.00 |
| Jun 30, 2021 | -573,343.00 |